Caxton Associates (UK)’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-47,260
Closed -$2.25M – 848
2026
Q2
$2.25M Buy
47,260
+8,522
+22% +$395K 0.04% 233
2026
Q1
$1.7M Buy
+38,738
New +$1.77M 0.04% 256
2025
Q4
– Sell
-13,471
Closed -$569K – 917
2025
Q3
$569K Sell
13,471
-44,682
-77% -$1.8M 0.01% 433
2025
Q2
$2.13M Buy
58,153
+1,561
+3% +$58K 0.05% 177
2025
Q1
$2.16M Buy
+56,592
New +$2.11M 0.08% 143

Other funds holding OHI

Caxton Associates (UK)'s OHI Position: Q3 2026 in Review

Caxton Associates (UK) sold out of Omega Healthcare (OHI) in Q3 2026, closing a stake of 47,260 shares — an estimated $2.25M sold.

Caxton Associates (UK) first reported a position in OHI in Q1 2025 and held it in 5 quarters. The position peaked at $2.25M in Q2 2026. 768 funds tracked by Wall St. Rank hold OHI as of Q3 2026.

  • Caxton Associates (UK) reported no remaining Omega Healthcare position as of Q3 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 47,260 Omega Healthcare shares in Q3 2026, an estimated $2.25M.
  • Caxton Associates (UK) first reported a position in Omega Healthcare in Q1 2025 and held it in 5 quarters.
  • Caxton Associates (UK)'s Omega Healthcare position peaked at $2.25M in Q2 2026.
  • 768 funds tracked by Wall St. Rank held Omega Healthcare as of Q3 2026.

Based on Caxton Associates (UK)'s 13F filing for Q3 2026, filed 13 Nov 2026.